- Communication
The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies
- Davide Di Tonno,
- Laura Martena,
- Manuela Taurisano,
- Caterina Perlin,
- Anna Chiara Loiacono,
- Stefano Lagravinese,
- Santo Marsigliante,
- Michele Maffia,
- Susanna Esposito and
- Alberto Argentiero
- + 6 authors
Phase I clinical trials represent a critical point in drug development because the investigational medicinal product is being tested in humans for the first time. For this reason, it is essential to evaluate and identify the Maximum Tolerated Dose (M...

